09:47 AM EST - Acerus Pharmaceuticals Corporation : Reported its financial results for the three-month period ended June 30, 2019. Unless otherwise noted, all amounts are in U.S. dollars. Total revenue in the quarter was $1.3 million compared to $2.1 million in the second quarter of 2018. The Company incurred a net loss of $3.2 million or $(0.01) per share for the quarter compared to a loss of $6.4 million or $(0.03) per share for the second quarter of 2018. Acerus Pharmaceuticals Corporation
shares T.ASP are trading down $0.01 at $0.13.
